Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
Regentis Biomaterials Ltd.
RGNT · SEC Filings
website
10
Regentis Biomaterials Ltd. is a regenerative medicine firm dedicated to crafting innovative solution...
Price
1.27
Market Cap
8.92 M
Float
5.72 M
Country
IL
Sector
Healthcare
Exchange
AMEX
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about RGNT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
Regentis Biomaterials Ltd.
RGNT · SEC Filings
5.72 M
Float
1.27
Price
8.92 M
Market Cap
Financials
TYPE
HEADLINE
FILED AT
20-F/A
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Feb 27, 2026
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 24, 2026
News
TYPE
HEADLINE
FILED AT
6-K
NEW
Regentis Signs Exclusive Distribution Agreement with AMI Technologies to Commercialize GelrinC® in Israel
Nov 9, 2026
6-K
Regentis Biomaterials Reports Strong Surgeon Interest in GelrinC® at 8th ICRS Summit in Portugal
Oct 13, 2026
6-K
Regentis Biomaterials Reports First Half 2026 Financial Results and Corporate Update
Sep 11, 2026
6-K
Regentis Receives Japanese Patent Allowance for Proprietary GelrinC Manufacturing Technology
Jul 20, 2026
6-K
Regentis Receives European Regulatory Approval for New GelrinC Manufacturing Process
Jul 15, 2026
6-K
Regentis Biomaterials Ltd. Announces Results of Adjourned Annual General Meeting
Jul 9, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B3
SHARE RESALE REGISTRATION | Shares: 3,807,143 | Bank: ThinkEquity LLC
Jul 13, 2026
424B3
UPDATED | SHARE RESALE REGISTRATION | Shares amount: 1,250,000 | Share price: $8 | Offering amount: $10,000,000
Dec 4, 2025
Registrations
TYPE
HEADLINE
FILED AT
Proxies
TYPE
HEADLINE
FILED AT
Ownerships
TYPE
HEADLINE
FILED AT
SCHEDULE 13G
Rosalind Advisors, Inc. (Filed by)
Aug 13, 2026
4
Alpert Susan PHD MD (Reporting)
Jul 13, 2026
4
Ben-Elazar Pini (Reporting)
Jul 13, 2026
4
Valentine Keith (Reporting)
Jul 13, 2026
4
Dykan Jeff (Reporting)
Jul 13, 2026
4
GELLER EHUD (Reporting)
Jul 13, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
EFFECT
Form EFFECT - Notice of Effectiveness
Sep 23, 2026
EFFECT
Form EFFECT - Notice of Effectiveness
Jul 14, 2026
CORRESP
Form CORRESP - Correspondence
Sep 17, 2025
CORRESP
Form CORRESP - Correspondence
Sep 17, 2025
CORRESP
Form CORRESP - Correspondence
Sep 15, 2025
CORRESP
Form CORRESP - Correspondence
Sep 15, 2025
